The 13th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI) Held jointly with The German Society of Obstetrics & Gynecology
DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. With net sales of nearly 5.9 billion € in fiscal year 2008, DAIICHI SANKYO is one of the world’s 20 leading pharmaceutical companies. The headquarter is in Tokyo. DAIICHI SANKYO has affiliates in 12 European countries and has been one of the strongest Japanese pharmaceutical companies in Europe. The company’s research activities focus on the areas of cardiovascular diseases, haematology, diabetes, anti-infectives and cancer. Its aim is to develop medications that are best in their class or to create new classes of pharmaceutical drugs.